Literature DB >> 2557

Microcapsule of type III strains of group B Streptococcus: production and morphology.

C J Baker, D L Kasper.   

Abstract

The yield of purified type III polysaccharide of group B Streptococcus was significantly improved by modification of the growth medium. Culture of organisms in standard Todd-Hewitt broth resulted in acid accumulation during the exponential phase of growth and poor yield of type III polysaccharide when extracted from cells by washing with neutral buffer solution. By increasing the buffering capacity of the broth medium, acid accumulation was prevented, and the number of viable cells was increased at the stationary phase of growth. Further, by increasing the concentration of glucose in the buffered medium, the yield of type III polysaccharide was increased two to three times. Electron microscopic investigations of cells grown in the modified broth medium demonstrated a thicker microcapsule than was found in organisms grown in standard broth.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 2557      PMCID: PMC420594          DOI: 10.1128/iai.13.1.189-194.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  Group B streptococcal infections in infants. The importance of the various serotypes.

Authors:  C J Baker; F F Barrett
Journal:  JAMA       Date:  1974-11-25       Impact factor: 56.272

2.  Immunochemical similarity between polysaccharide antigens of Escherichia coli 07: K1(L):NM and group B Neisseria meningitidis.

Authors:  D L Kasper; J L Winkelhake; W D Zollinger; B L Brandt; M S Artenstein
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

Review 3.  Endotoxins and bacterial virulence.

Authors:  D Rowley
Journal:  J Infect Dis       Date:  1971-03       Impact factor: 5.226

4.  Type-specific polysaccharide antigens of group B streptococci.

Authors:  R C Lancefield; E H Freimer
Journal:  J Hyg (Lond)       Date:  1966-06

5.  Fine structures of capillary and endocapillary layer as revealed by ruthenium red.

Authors:  J H Luft
Journal:  Fed Proc       Date:  1966 Nov-Dec

6.  Type-specific antigens of group B type Ic streptococci.

Authors:  H W Wilkinson; R G Eagon
Journal:  Infect Immun       Date:  1971-11       Impact factor: 3.441

7.  Electron microscopic studies on streptococci. II. Group A carbohydrate.

Authors:  J Swanson; E C Gotschlich
Journal:  J Exp Med       Date:  1973-07-01       Impact factor: 14.307

8.  Release of endotoxin in the form of cell wall blebs during in vitro growth of Neisseria meningitidis.

Authors:  I W Devoe; J E Gilchrist
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

9.  Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen.

Authors:  E H Freimer
Journal:  J Exp Med       Date:  1967-03-01       Impact factor: 14.307

  9 in total
  38 in total

1.  Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants.

Authors:  V J Benedí; B Ciurana; J M Tomás
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

2.  Adherence of group B streptococci to human buccal epithelial cells, its dependence on the biological state of the culture.

Authors:  V Kubín; M Rýc
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

3.  Surface protein of a Streptococcus agalactiae isolate.

Authors:  B J de Cueninck
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

4.  Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci.

Authors:  T W Milligan; C J Baker; D C Straus; S J Mattingly
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody.

Authors:  E B Mackie; K N Brown; J Lam; J W Costerton
Journal:  J Bacteriol       Date:  1979-05       Impact factor: 3.490

6.  Strain specificity of opsonins for group B streptococci types II and III.

Authors:  A O Shigeoka; R T Hall; H R Hill
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

7.  Guanidine extraction enhances the binding of human fibrinogen to group-B streptococci.

Authors:  G S Chhatwal; C Lämmler; H Blobel
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

8.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

9.  Opsonin-independent phagocytosis of group B streptococci: role of complement receptor type three.

Authors:  J M Antal; J V Cunningham; K J Goodrum
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Characterization of neuraminidases produced by various serotypes of group B streptococci.

Authors:  J G Brown; D C Straus
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.